Home » Stocks » Pressure BioSciences

Pressure BioSciences Inc. (PBIO)

Stock Price: $2.10 USD 0.10 (5.00%)
Updated Aug 14, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 6.63M
Revenue (ttm) 1.55M
Net Income (ttm) -13.56M
Shares Out 3.16M
EPS (ttm) -7.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $2.10
Previous Close $2.00
Change ($) 0.10
Change (%) 5.00%
Day's Open 1.88
Day's Range 1.88 - 2.23
Day's Volume 10,012
52-Week Range 0.60 - 4.49

More Stats

Market Cap 6.63M
Enterprise Value 15.28M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 3.16M
Float 3.06M
EPS (basic) -7.73
EPS (diluted) -7.52
FCF / Share -2.30
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 6,336
Short Ratio 3.00
Short % of Float 3.64%
Beta 0.97
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.27
PB Ratio n/a
Revenue 1.55M
Operating Income -5.80M
Net Income -13.56M
Free Cash Flow -6.09M
Net Cash -8.65M
Net Cash / Share -2.74
Gross Margin -35.03%
Operating Margin -373.57%
Profit Margin -1,073.30%
FCF Margin -391.67%
ROA -167.33%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$12.00*
Low
12.0
Current: $2.10
High
12.0
Target: 12.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1.812.462.241.981.801.371.501.240.991.34
Revenue Growth-26.36%9.7%13.36%9.95%30.77%-8.55%21.41%25.36%-26.29%-
Gross Profit0.611.180.971.141.190.720.940.820.640.96
Operating Income-5.81-4.48-4.65-3.74-3.57-3.34-3.33-3.46-3.29-3.40
Net Income-11.66-9.70-10.72-2.71-7.42-4.61-4.08-3.45-3.00-3.13
Shares Outstanding1.991.531.110.910.690.480.390.340.220.09
Earnings Per Share-7.98-15.33-9.62-2.97-10.77-13.20-13.20-12.90-23.10-40.50
Operating Cash Flow-6.33-5.70-3.90-3.81-3.82-3.21-2.34-2.16-2.14-2.87
Capital Expenditures-0.02--0.02-0.01-0.01-0.01-0.06---0.09
Free Cash Flow-6.35-5.70-3.93-3.81-3.83-3.22-2.40-2.16-2.14-2.96
Cash & Equivalents0.030.100.080.140.120.470.030.010.230.58
Total Debt7.965.0013.175.510.431.080.471.040.54-
Net Cash / Debt-7.93-4.90-13.09-5.37-0.31-0.61-0.44-1.03-0.320.58
Assets1.822.402.161.631.801.741.101.351.942.59
Liabilities13.878.5216.7810.019.783.803.072.892.350.78
Book Value-12.06-6.13-14.62-8.38-7.98-2.06-1.97-1.54-0.411.81
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Pressure BioSciences Inc.
Country United States
Employees 14
CEO Richard T. Schumacher

Stock Information

Ticker Symbol PBIO
Stock Exchange US OTC
Sector Healthcare
Industry Medical Devices
Unique Identifier OTCMKTS: PBIO
IPO Date October 31, 1996

Description

Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions in North America, Europe, and Asia. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as pressure used to lyse samples for extraction tubes and other processing tubes, as well as application specific kits, including consumable products and reagents. It serves government institutions, pharmaceutical and biotechnology companies, and academic laboratories. Pressure BioSciences, Inc. has a collaboration with The Steinbeis Centre for biopolymer analysis and biomedical mass spectrometry; and NutraLife Biosciences for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.